<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00155233</url>
  </required_header>
  <id_info>
    <org_study_id>931002</org_study_id>
    <nct_id>NCT00155233</nct_id>
  </id_info>
  <brief_title>Interaction Between Nalbuphine and Morphine in PCA</brief_title>
  <official_title>Interaction Between Nalbuphine and Morphine in Postoperative PCA for Gynecologic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist

        2. This study was designed to investigate the interaction between nalbuphine and morphine
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Nalbuphine is opioid mu receptor antagonist and kappa receptor agonist

        2. This study was designed to investigate the interaction between nalbuphine and morphine

        3. The analgesic effect and opioid-related side effects will be investigated
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic effect</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of opioid-related side effects</measure>
  </secondary_outcome>
  <enrollment>200</enrollment>
  <condition>Postoperative Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nalbuphine and morphine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-65 y/o

          2. Female patients of ASA physical status I to III

          3. Scheduled for elective abdominal hysterectomy, myomectomy, or excision of ovarian
             tumor

        Exclusion Criteria:

          1. Patients with a definite diagnosis of chronic pain syndrome, psychiatric disorders, or
             drug abuse (include opioids, NSAIDs, sedatives, antidepressants)

          2. Intraoperative fentanyl use &gt; 3 Î¼g/kg

          3. Patients with definite diagnosis of esophageal reflux syndrome

          4. Use of sedatives, antiemetics, or antipruritics within 24 hours before operation

          5. Surgery &gt; 4 hours or laparoscopy surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei-Zen Sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Chang Yeh, MD</last_name>
      <email>cooltony@ha.mc.ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Wei-Zen Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2005</study_first_submitted>
  <study_first_submitted_qc>September 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>November 22, 2005</last_update_submitted>
  <last_update_submitted_qc>November 22, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2005</last_update_posted>
  <keyword>analgeisa</keyword>
  <keyword>postoperatve</keyword>
  <keyword>side effects</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

